|
ES2364340T3
(es)
*
|
2004-03-30 |
2011-08-31 |
Vertex Pharmaceuticals Incorporated |
Azaindoles útiles como inhibidores de jak y otras proteína quinasas.
|
|
EP2354140A1
(en)
*
|
2005-05-20 |
2011-08-10 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
CA2621261C
(en)
|
2005-09-22 |
2014-05-20 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
|
SG10202003901UA
(en)
|
2005-12-13 |
2020-05-28 |
Incyte Holdings Corp |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
|
ES2545907T3
(es)
*
|
2005-12-29 |
2015-09-16 |
Abbvie Inc. |
Inhibidores de proteína quinasa
|
|
UA95940C2
(uk)
|
2006-01-17 |
2011-09-26 |
Вертекс Фармасьютикалс Інкорпорейтед |
Азаіндоли як інгібітори кіназ януса
|
|
SG170828A1
(en)
*
|
2006-04-05 |
2011-05-30 |
Vertex Pharmaceuticals Inc Us |
Deazapurines useful as inhibitors of janus kinases
|
|
AU2007287428B2
(en)
|
2006-08-24 |
2011-08-11 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
|
|
CN101678022A
(zh)
|
2006-12-21 |
2010-03-24 |
弗特克斯药品有限公司 |
可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物
|
|
CA2673038C
(en)
|
2006-12-22 |
2015-12-15 |
Incyte Corporation |
Substituted tricyclic heteroaryl compounds as janus kinase inhibitors
|
|
MX2009010127A
(es)
*
|
2007-03-22 |
2009-11-05 |
Vertex Pharma |
Compuestos utiles como inhibidores de janus cinasas.
|
|
KR20150036210A
(ko)
|
2007-06-13 |
2015-04-07 |
인사이트 코포레이션 |
야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
CN101809002B
(zh)
|
2007-07-09 |
2013-03-27 |
阿斯利康(瑞典)有限公司 |
用于与mtor激酶和/或pi3k相关的疾病中的吗啉代嘧啶衍生物
|
|
CN101932583A
(zh)
*
|
2007-12-19 |
2010-12-29 |
沃泰克斯药物股份有限公司 |
用作JAK2抑制剂的吡唑并[1,5-a]嘧啶类
|
|
DE102008005493A1
(de)
*
|
2008-01-22 |
2009-07-23 |
Merck Patent Gmbh |
4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
|
|
HUE029767T2
(en)
|
2008-03-11 |
2017-04-28 |
Incyte Holdings Corp |
JAK inhibitor azetidine and cyclobutane derivatives
|
|
JP2011515462A
(ja)
*
|
2008-03-27 |
2011-05-19 |
アウククランド ウニセルビセス リミテッド |
置換されたピリミジン、及びトリアジン、並びに癌療法におけるこれらの使用
|
|
KR101608456B1
(ko)
*
|
2008-07-09 |
2016-04-01 |
닛산 가가쿠 고교 가부시키 가이샤 |
이속사졸린 치환 안식향산 아미드 화합물의 제조 방법
|
|
GB2465405A
(en)
*
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
|
SI2432472T1
(sl)
|
2009-05-22 |
2019-11-29 |
Incyte Holdings Corp |
3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK
|
|
AR076794A1
(es)
|
2009-05-22 |
2011-07-06 |
Incyte Corp |
Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen
|
|
LT3141252T
(lt)
|
2009-06-17 |
2018-11-12 |
Vertex Pharmaceuticals Inc. |
Gripo virusų replikacijos inhibitoriai
|
|
WO2011012283A1
(en)
*
|
2009-07-30 |
2011-02-03 |
University Of Zurich |
Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
EA021478B1
(ru)
|
2009-10-09 |
2015-06-30 |
Инсайт Корпорейшн |
ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
|
|
ES2426407T3
(es)
|
2009-10-15 |
2013-10-23 |
Pfizer Inc. |
Compuestos de pirrolo[2,3-d]pirimidina
|
|
ES2629006T3
(es)
*
|
2009-10-29 |
2017-08-07 |
Vectura Limited |
Derivados que contienen N-heteroarilo como inhibidores de la quinasa jak3
|
|
WO2011075334A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidine compounds
|
|
JP5769733B2
(ja)
*
|
2010-01-27 |
2015-08-26 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
ピラゾロピリジンキナーゼ阻害剤
|
|
MX2012008642A
(es)
*
|
2010-01-27 |
2012-11-23 |
Vertex Pharma |
Inhibidores de cinasas de pirazolopiridinas.
|
|
EP3354652B1
(en)
|
2010-03-10 |
2020-05-06 |
Incyte Holdings Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
PE20130216A1
(es)
|
2010-05-21 |
2013-02-27 |
Incyte Corp |
Formulacion topica para un inhibidor de jak
|
|
SA111320519B1
(ar)
|
2010-06-11 |
2014-07-02 |
Astrazeneca Ab |
مركبات بيريميدينيل للاستخدام كمثبطات atr
|
|
PE20140146A1
(es)
|
2010-11-19 |
2014-02-06 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
|
US9034884B2
(en)
|
2010-11-19 |
2015-05-19 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
|
|
CN103562205A
(zh)
*
|
2010-12-16 |
2014-02-05 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
|
RU2013132681A
(ru)
|
2010-12-16 |
2015-01-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы репликации вирусов гриппа
|
|
ES2547916T3
(es)
|
2011-02-18 |
2015-10-09 |
Novartis Pharma Ag |
Terapia de combinación de inhibidores de mTOR/JAK
|
|
CN103797010B
(zh)
|
2011-06-20 |
2016-02-24 |
因塞特控股公司 |
作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
EP2741747A1
(en)
|
2011-08-10 |
2014-06-18 |
Novartis Pharma AG |
JAK P13K/mTOR COMBINATION THERAPY
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
EP2788000B1
(en)
*
|
2011-12-06 |
2018-05-30 |
Merck Sharp & Dohme Corp. |
Pyrrolopyrimidines as janus kinase inhibitors
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
WO2014013014A1
(en)
|
2012-07-18 |
2014-01-23 |
Fundació Privada Centre De Regulació Genòmica (Crg) |
Jak inhibitors for activation of epidermal stem cell populations
|
|
PH12020551186B1
(en)
|
2012-11-15 |
2024-03-20 |
Incyte Holdings Corp |
Sustained-release dosage forms of ruxolitinib
|
|
RS62867B1
(sr)
|
2013-03-06 |
2022-02-28 |
Incyte Holdings Corp |
Postupci i intermedijeri za dobijanje inhibitora jak
|
|
WO2014145576A2
(en)
|
2013-03-15 |
2014-09-18 |
Northwestern University |
Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer
|
|
SMT202000315T1
(it)
|
2013-08-07 |
2020-07-08 |
Incyte Corp |
Forme di dosaggio a rilascio prolungato per un inibitore di jak1
|
|
JP6618901B2
(ja)
|
2013-11-13 |
2019-12-11 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
|
LT3068776T
(lt)
|
2013-11-13 |
2019-08-12 |
Vertex Pharmaceuticals Incorporated |
Gripo virusų replikacijos inhibitoriai
|
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
|
AR101196A1
(es)
|
2014-07-16 |
2016-11-30 |
Gruenenthal Gmbh |
Compuestos de pirimidina sustituidos
|
|
AR101197A1
(es)
*
|
2014-07-16 |
2016-11-30 |
Gruenenthal Gmbh |
Pirimidinas 2,5-sustituidas
|
|
AR101198A1
(es)
|
2014-07-16 |
2016-11-30 |
Gruenenthal Gmbh |
Pirimidinas 2,5-sustituidas como inhibidores de pde4b
|
|
TWI679205B
(zh)
*
|
2014-09-02 |
2019-12-11 |
日商日本新藥股份有限公司 |
吡唑并噻唑化合物及醫藥
|
|
ES2860688T3
(es)
|
2014-09-08 |
2021-10-05 |
Janssen Sciences Ireland Uc |
Pirrolopirimidinas para uso en la infección por el virus de la gripe
|
|
EP3294717B1
(en)
|
2015-05-13 |
2020-07-29 |
Vertex Pharmaceuticals Inc. |
Methods of preparing inhibitors of influenza viruses replication
|
|
EP3294735B8
(en)
|
2015-05-13 |
2022-01-05 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
JP6903658B2
(ja)
|
2015-11-27 |
2021-07-14 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
インフルエンザウィルス感染に使用するための複素環インドール
|
|
MX381314B
(es)
|
2016-01-20 |
2025-03-12 |
Janssen Sciences Ireland Uc |
Pirimidinas sustituidas con arilo para su uso en la infeccion por virus influenza
|
|
WO2017133669A1
(en)
*
|
2016-02-05 |
2017-08-10 |
Savira Pharmaceuticals Gmbh |
5, 7-diazaindole and 5, 7-diazaindazole derivatives and their use in the treatment, amelioration or prevention of influenza
|
|
TWI712604B
(zh)
*
|
2016-03-01 |
2020-12-11 |
日商日本新藥股份有限公司 |
具jak抑制作用之化合物之結晶
|
|
CN109311882B
(zh)
*
|
2016-05-04 |
2022-02-11 |
Bci制药公司 |
作为蛋白激酶抑制剂的腺嘌呤衍生物
|
|
KR102598246B1
(ko)
*
|
2016-07-26 |
2023-11-02 |
톈진 롱보진 파마시우티컬 씨오., 엘티디. |
Jak 저해제로서 헤테로사이클릭 화합물, 및 이의 염 및 치료학적 용도
|
|
WO2018041989A1
(en)
|
2016-09-02 |
2018-03-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing and treating refractory celiac disease type 2
|
|
EA039352B1
(ru)
*
|
2017-01-19 |
2022-01-17 |
Сучжоу Лонгбайотек Фармасьютикалз Ко., Лтд. |
Соединение в качестве селективного ингибитора jak и его соли и терапевтическое применение
|
|
WO2018157830A1
(en)
*
|
2017-03-02 |
2018-09-07 |
Sunshine Lake Pharma Co., Ltd. |
Inhibitors of influenza virus replication and uses thereof
|
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
SG11202007164UA
(en)
|
2018-01-30 |
2020-08-28 |
Incyte Corp |
Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
|
|
SMT202400306T1
(it)
|
2018-03-30 |
2024-09-16 |
Incyte Corp |
Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak.
|
|
CN109293640B
(zh)
*
|
2018-10-31 |
2020-05-19 |
青岛清原化合物有限公司 |
一种取代的含氮杂芳环甲酰胺衍生物及其除草组合物和用途
|
|
EP3947737A2
(en)
|
2019-04-02 |
2022-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting and preventing cancer in patients having premalignant lesions
|
|
EP3955920A1
(en)
|
2019-04-16 |
2022-02-23 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Use of jak inhibitors for the treatment of painful conditions involving nav1.7 channels
|
|
CA3139277A1
(en)
|
2019-05-08 |
2020-11-12 |
Vimalan Biosciences, Inc. |
Jak inhibitors
|
|
MX2022001702A
(es)
|
2019-08-08 |
2022-04-20 |
Vimalan Biosciences Inc |
Inhibidores de jak.
|
|
US20230024521A1
(en)
*
|
2019-09-25 |
2023-01-26 |
Vimalan Biosciences, Inc. |
Jak inhibitors
|
|
US20220372135A1
(en)
|
2019-09-27 |
2022-11-24 |
Disc Medicine, Inc. |
Methods for treating myelofibrosis and related conditions
|
|
KR20230012539A
(ko)
|
2020-05-13 |
2023-01-26 |
디스크 메디슨, 인크. |
골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
WO2023222565A1
(en)
|
2022-05-16 |
2023-11-23 |
Institut National de la Santé et de la Recherche Médicale |
Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation
|